OOIR: Observatory of International Research

Papers

(The H4-Index of Circulation is 540. The table below lists those papers that are above that threshold based on CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-03-01 to 2023-03-01.)

Article	Citations
Heart Rate Variability	9706
PhysioBank, PhysioToolkit, and PhysioNet	7982
Prediction of Coronary Heart Disease Using Risk Factor Categories	6216
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.	5430
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.	5290
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association	4694
Markers of Inflammation and Cardiovascular Disease	4411
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines	4083
Definition of Metabolic Syndrome	3647
Impact of Atrial Fibrillation on the Risk of Death	3197
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.	3112
Heart Disease and Stroke Statistics—2014 Update	2964
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.	2620
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults	2591
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease	2485
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease	2459
Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac Surgery	2452
Cardiovascular neural regulation explored in the frequency domain.	2412
Coronary Plaque Disruption	2338
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Associati	2231
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies	2228
Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis	2220
Atrial Fibrillation Begets Atrial Fibrillation	2176
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.	2107
The stunned myocardium: prolonged, postischemic ventricular dysfunction.	2062
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk	2045
Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures	2032
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction	1956
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.	1916
From Vulnerable Plaque to Vulnerable Patient	1901
Cardiovascular Mortality and Long-Term Exposure to Particulate Air Pollution	1825
Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function	1777
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease	1753
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis	1733
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.	1708
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.	1701
Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells	1683
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events	1669
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy	1668
Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention	1647
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)	1646
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome	1607
Air Pollution and Cardiovascular Disease	1571
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises	1567
Novel Modulator for Endothelial Adhesion Molecules	1552
Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans	1545
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.	1530
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals	1527
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men	1522
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults	1521
Hemodynamic Patterns of Age-Related Changes in Blood Pressure	1460
The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.	1451
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four con	1450
Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction	1449
Lifetime Risk for Development of Atrial Fibrillation	1435
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease	1421
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality	1360
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction	1336
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans	1330
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease	1330
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary	1323
Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors	1321
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults	1316
Diabetes and Cardiovascular Disease	1313
Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators	1306
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Tas	1305
Brugada Syndrome: Report of the Second Consensus Conference	1303
Total Excitation of the Isolated Human Heart	1302
Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States	1302
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease	1293
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.	1280
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men	1276
Transluminal Treatment of Arteriosclerotic Obstruction	1275
Genotype-Phenotype Correlation in the Long-QT Syndrome	1269
Atherogenesis: a postprandial phenomenon.	1267
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update	1266
Sudden Cardiac Death	1260
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults	1254
Molecular Bases of the Acute Coronary Syndromes	1249
Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-κB Signaling Through a cAMP-Dependent Pathway	1245
Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure.	1236
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors	1224
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention	1212
Impact of Reduced Heart Rate Variability on Risk for Cardiac Events	1211
Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions	1199
TIMI Frame Count	1199
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction	1195
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism	1191
Survival after the onset of congestive heart failure in Framingham Heart Study subjects.	1191
Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.	1190
Left Ventricular Remodeling After Myocardial Infarction	1188
Clopidogrel for Coronary Stenting	1186
Quantification of Myocardial Blood Flow With Ultrasound-Induced Destruction of Microbubbles Administered as a Constant Venous Infusion	1178
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.	1170
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells	1168
Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion S	1163
Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent	1151
Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance	1149
An updated coronary risk profile. A statement for health professionals.	1147
Right ventricular dysplasia: a report of 24 adult cases.	1147
Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports	1146
Stroke Prevention in Atrial Fibrillation Study. Final results.	1136
Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease?	1135
Atherosclerosis: Basic Mechanisms	1132
Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures	1132
AHA Dietary Guidelines	1127
Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population	1123
Lifetime Risk for Developing Congestive Heart Failure	1117
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure	1108
Frequency domain measures of heart period variability and mortality after myocardial infarction.	1100
Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation	1098
Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo	1096
Executive Summary: Heart Disease and Stroke Statistics—2014 Update	1095
Socioeconomic factors and cardiovascular disease: a review of the literature.	1091
Canadian Implantable Defibrillator Study (CIDS)	1080
Plasticity of Human Adipose Lineage Cells Toward Endothelial Cells	1075
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study	1072
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.	1057
Depression and 18-Month Prognosis After Myocardial Infarction	1055
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women	1038
Prognostic Value of Coronary Vascular Endothelial Dysfunction	1032
Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?	1032
Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, t	1030
Ischemic Mitral Regurgitation	1024
Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction	1021
Role of Endothelial Dysfunction in Atherosclerosis	1007
Promotion of Atrial Fibrillation by Heart Failure in Dogs	1003
Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction	998
Human blood pressure determination by sphygmomanometry.	997
Inflammation as a Risk Factor for Atrial Fibrillation	992
Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms	990
The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.	987
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).	987
Intracoronary Stenting Without Anticoagulation Accomplished With Intravascular Ultrasound Guidance	986
Prognostic Significance of Microvascular Obstruction by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction	986
Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.	985
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes	982
Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.	979
Color Doppler assessment of mitral regurgitation with orthogonal planes.	978
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation	977
Imaging Atherosclerotic Plaque Inflammation With [ ¹⁸ F]-Fluorodeoxyglucose Positron Emission Tomography	976
Coronary Artery Calcium Area by Electron-Beam Computed Tomography and Coronary Atherosclerotic Plaque Area	975
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Grou	971
Overweight in Children and Adolescents	970
Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Pulmonary Veins	970
Increased Particulate Air Pollution and the Triggering of Myocardial Infarction	969
Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest	969
The Pathology of Hypertensive Pulmonary Vascular Disease	965
Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction	953
Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure	952
The Epidemiology of Venous Thromboembolism	950
Circadian variation and triggers of onset of acute cardiovascular disease.	946
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein	946
Improving survival from sudden cardiac arrest: the "chain of survival" concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care	946
Nonpenetrating Traumatic Injury of the Aorta	942
Estimation of Central Aortic Pressure Waveform by Mathematical Transformation of Radial Tonometry Pressure	942
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.	941
Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives	938
Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease	937
Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine Concentrations	935
Mutations in the Cardiac Ryanodine Receptor Gene ( hRyR2 ) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia	932
Metabolic Syndrome	930
Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.	929
Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia	929
An overview of randomized trials of rehabilitation with exercise after myocardial infarction.	924
Long-term Consequences of Kawasaki Disease	924
Characterization of Human Atherosclerosis by Optical Coherence Tomography	924
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.	924
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.	923
Isolated noncompaction of left ventricular myocardium. A study of eight cases.	922
Angiographic Assessment of Myocardial Reperfusion in Patients Treated With Primary Angioplasty for Acute Myocardial Infarction	922
Approaches to Sudden Death from Coronary Heart Disease	916
Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data.	916
Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation	916
Incidence of and Risk Factors for Atrial Fibrillation in Older Adults	916
Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium	915
Angiographic Patterns of In-Stent Restenosis	914
Differentiation of Human Embryonic Stem Cells to Cardiomyocytes	904
Systolic Time Intervals in Heart Failure in Man	901
Diabetes and Vascular Disease	899
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.	899
Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages	898
Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure	897
Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis	896
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk	891
Hypertrophic Cardiomyopathy	890
State of Disparities in Cardiovascular Health in the United States	888
Circulating Adhesion Molecules VCAM-1, ICAM-1, and E-selectin in Carotid Atherosclerosis and Incident Coronary Heart Disease Cases	888
Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization	885
Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.	883
Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure	883
Unstable angina. A classification.	875
High-Sensitivity C-Reactive Protein	873
Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure	871
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure	871
Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels	861
Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia	857
Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction.	856
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study	856
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises	855
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis	855
Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium-Enhanced Cardiovascular Magnetic Resonance	853
High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.	852
Patterns and Mechanisms of In-Stent Restenosis	852
Current Perspectives on Statins	850
Incremental Prognostic Value of Myocardial Perfusion Single Photon Emission Computed Tomography for the Prediction of Cardiac Death	849
Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in to	846
Spectrum of Mutations in Long-QT Syndrome Genes	846
Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?	841
From Vulnerable Plaque to Vulnerable Patient	838
ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article	834
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.	829
The Electrocardiogram in Population Studies	826
Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases	825
Diabetes and cardiovascular risk factors: the Framingham study.	823
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.	823
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.	823
Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia	822
Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man	821
Congenital Heart Disease in 56,109 Births Incidence and Natural History	820
Coronary Plaque Erosion Without Rupture Into a Lipid Core	820
Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.	810
Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal	810
Endothelial Function	807
Survival in Primary Pulmonary Hypertension	805
Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction	804
Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure	802
An Accurate, Clinically Practical System For Spatial Vectorcardiography	800
Effect of Pacing Chamber and Atrioventricular Delay on Acute Systolic Function of Paced Patients With Congestive Heart Failure	800
Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart	797
The VIVA Trial	796
Cardiac troponin I. A marker with high specificity for cardiac injury.	795
Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events	795
Myocardial Strain by Doppler Echocardiography	792
Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice	788
Cardiovascular Magnetic Resonance Assessment of Human Myocarditis	787
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure	785
Nifedipine	783
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.	783
Circadian variation in the frequency of sudden cardiac death.	783
Catheter Technique for Recording His Bundle Activity in Man	779
Sleep Apnea in 81 Ambulatory Male Patients With Stable Heart Failure	778
Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions	775
Cellular Basis for the Brugada Syndrome and Other Mechanisms of Arrhythmogenesis Associated With ST-Segment Elevation	772
Arterial Stiffness, Wave Reflections, and the Risk of Coronary Artery Disease	772
Linear Ablation Lesions for Control of Unmappable Ventricular Tachycardia in Patients With Ischemic and Nonischemic Cardiomyopathy	772
Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation	771
Constitutive Expression of phVEGF ₁₆₅ After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia	768
Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men	768
Our Preoccupation With Coronary Luminology	767
Noninvasive determination of age-related changes in the human arterial pulse.	766
Some Aspects of the Biological Role of Adenosine 3',5'-monophosphate (Cyclic AMP)	764
Association of Atrial Fibrillation and Obstructive Sleep Apnea	764
Postoperative Course and Hemodynamic Profile After the Arterial Switch Operation in Neonates and Infants	761
Aging, Habitual Exercise, and Dynamic Arterial Compliance	757
Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation for Paroxysmal Atrial Fibrillation	754
Sympathovagal Balance	751
Predictors of Atrial Fibrillation After Coronary Artery Surgery	751
Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt.	750
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.	748
Aortocoronary Saphenous Vein Graft Disease	746
Diagnostic criteria for the long QT syndrome. An update.	744
Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population	740
The prevalence of peripheral arterial disease in a defined population.	739
Left Atrial Size and the Risk of Stroke and Death	739
Randomized, Controlled Trial of Long-Term Moderate Exercise Training in Chronic Heart Failure	739
Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium	739
Prospective Study of Asymptomatic Valvular Aortic Stenosis	739
Endothelial Cell Senescence in Human Atherosclerosis	738
Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States	738
Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure	737
Physiological Analysis of Middle-Aged and Old Former Athletes	733
Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus	730
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2	730
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study.	729
Effects of age and aerobic capacity on arterial stiffness in healthy adults.	725
A Self-Fulfilling Prophecy	725
Statin Therapy Accelerates Reendothelialization	723
Coronary Artery Calcification: Pathophysiology, Epidemiology, Imaging Methods, and Clinical Implications	722
Impact of Obesity on Plasma Natriuretic Peptide Levels	721
Aortic input impedance in normal man: relationship to pressure wave forms.	720
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis	720
Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes	719
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.	719
Exercise and Heart Failure	714
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.	713
Primary pulmonary hypertension: natural history and the importance of thrombosis.	713
Clinical Implications of the ‘No Reflow’ Phenomenon	713
Reliable Noninvasive Coronary Angiography With Fast Submillimeter Multislice Spiral Computed Tomography	712
Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients	712
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.	712
Cytokines and Cytokine Receptors in Advanced Heart Failure	711
Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale	710
Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction	710
Insights Into Causal Pathways for Ischemic Heart Disease	706
Prevalence of the Metabolic Syndrome in American Adolescents	706
Detection of Coronary Artery Stenoses With Thin-Slice Multi-Detector Row Spiral Computed Tomography and Multiplanar Reconstruction	705
β-Adrenergic Receptor Blockade in Chronic Heart Failure	704
Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction	704
Supravalvular Aortic Stenosis	703
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.	702
Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome	701
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.	700
Congestive Heart Failure in the Community	700
Continuous measurement of left ventricular volume in animals and humans by conductance catheter.	700
Cellular Basis for the Normal T Wave and the Electrocardiographic Manifestations of the Long-QT Syndrome	698
Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.	698
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.	697
In Vivo Characterization of Coronary Atherosclerotic Plaque by Use of Optical Coherence Tomography	697
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock	696
Double-Blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination With Aspirin Compared With Ticlopidine in Combination With Aspirin After Coronary Stenting	695
Improvement of Postnatal Neovascularization by Human Adipose Tissue-Derived Stem Cells	692
Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.	691
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.	691
Catheter Ablation for Paroxysmal Atrial Fibrillation	690
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombol	689
Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques	689
Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction.	689
Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.	687
Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work.	686
Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.	685
Atrio-Esophageal Fistula as a Complication of Percutaneous Transcatheter Ablation of Atrial Fibrillation	685
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises	684
Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion	684
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.	683
Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction	683
Left Ventricular Hypertrophy	681
Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography.	679
Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure	679
Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure	678
Gene Therapy for Myocardial Angiogenesis	678
Mechanism of myocardial "stunning".	677
Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.	677
Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality	677
Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.	675
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart	675
Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation	675
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.	674
A Focal Source of Atrial Fibrillation Treated by Discrete Radiofrequency Ablation	674
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients	673
Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels	672
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.	671
Inflammatory Markers and Onset of Cardiovascular Events	671
Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease	671
Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?	669
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations	669
Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.	667
The long QT syndrome. Prospective longitudinal study of 328 families.	665
Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community.	664
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure	664
Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease	663
Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation	662
Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus	660
Diagnosis and Treatment of Fetal Cardiac Disease	659
Bone Formation and Inflammation in Cardiac Valves	658
Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month	657
Birth Weight and Adult Hypertension, Diabetes Mellitus, and Obesity in US Men	657
Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis	656
Oxidative Stress and Cardiovascular Injury	655
Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction	655
Elevated Levels of C-Reactive Protein and Interleukin-6 in Patients With Obstructive Sleep Apnea Syndrome Are Decreased by Nasal Continuous Positive Airway Pressure	654
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article	654
Effects of adenosine on human coronary arterial circulation.	652
Improved Left Ventricular Mechanics From Acute VDD Pacing in Patients With Dilated Cardiomyopathy and Ventricular Conduction Delay	652
Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.	651
Detection of Calcified and Noncalcified Coronary Atherosclerotic Plaque by Contrast-Enhanced, Submillimeter Multidetector Spiral Computed Tomography	648
Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy	647
TAXUS I	647
High-density mapping of electrically induced atrial fibrillation in humans.	646
Hypertriglyceridemic Waist	646
Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease	645
B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure	645
Chronic Rapid Atrial Pacing	644
Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary Angioplasty	641
Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea	640
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)	639
Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury	638
Resistin Is an Inflammatory Marker of Atherosclerosis in Humans	637
Catecholaminergic Polymorphic Ventricular Tachycardia in Children	637
Diagnosis and Treatment of Chronic Arterial Insufficiency of the Lower Extremities: A Critical Review	637
Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function.	635
Emerging Epidemic of Cardiovascular Disease in Developing Countries	634
Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging	634
Regular Physical Activity Improves Endothelial Function in Patients With Coronary Artery Disease by Increasing Phosphorylation of Endothelial Nitric Oxide Synthase	634
Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure	631
Hypertrophy of the Heart	629
Electrophysiological Breakthroughs From the Left Atrium to the Pulmonary Veins	629
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure	629
C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction	625
Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction.	625
Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations.	625
Bidirectional Relation Between Inflammation and Coagulation	623
Interobserver variability in coronary angiography.	621
Regular Physical Exercise Corrects Endothelial Dysfunction and Improves Exercise Capacity in Patients With Chronic Heart Failure	621
Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease	620
Aneurysmal coronary artery disease.	620
Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction	620
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.	620
Mechanism Linking T-Wave Alternans to the Genesis of Cardiac Fibrillation	619
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiova	619
Complete Isolation of Left Atrium Surrounding the Pulmonary Veins	618
Clinical Management of Metabolic Syndrome	617
Thoracic and Abdominal Aortic Aneurysms	615
The Athlete’s Heart	615
Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries	615
Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome	615
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis	614
Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea	614
Pravastatin and the Development of Diabetes Mellitus	614
Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients	613
Essential Hypertension	612
Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions	612
Hyperventilation-Induced Hypotension During Cardiopulmonary Resuscitation	611
Risk Factors for Venous Thromboembolism	610
Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.	610
Akt Promotes Survival of Cardiomyocytes In Vitro and Protects Against Ischemia-Reperfusion Injury in Mouse Heart	610
Platelet aggregation in partially obstructed vessels and its elimination with aspirin.	609
Identification of Patients at Increased Risk of First Unheralded Acute Myocardial Infarction by Electron-Beam Computed Tomography	609
Stent Thrombosis in the Modern Era	609
Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG	609
Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model	607
Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function	605
Electrophysiological End Point for Catheter Ablation of Atrial Fibrillation Initiated From Multiple Pulmonary Venous Foci	603
Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction.	603
Guide to the Assessment of Physical Activity: Clinical and Research Applications	603
Coronary Anomalies	602
Pathology of Acute and Chronic Coronary Stenting in Humans	602
Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes	602
Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window.	601
Arrhythmogenic Right Ventricular Cardiomyopathy	600
Regular Aerobic Exercise Prevents and Restores Age-Related Declines in Endothelium-Dependent Vasodilation in Healthy Men	600
Relationship of TIMI Myocardial Perfusion Grade to Mortality After Administration of Thrombolytic Drugs	600
Impact of Diabetes on Cardiac Structure and Function	600
Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation	600
Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus	598
Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis	598
Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins	598
Elevated Levels of Shed Membrane Microparticles With Procoagulant Potential in the Peripheral Circulating Blood of Patients With Acute Coronary Syndromes	597
Ambient Pollution and Heart Rate Variability	595
One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent	595
Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators	594
Case Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies	594
Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of cli	593
Initial and 6-Month Results of Biodegradable Poly- l -Lactic Acid Coronary Stents in Humans	593
Fractional Flow Reserve	593
Electron-Beam Tomography Coronary Artery Calcium and Cardiac Events	593
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines	592
Classification of Human Carotid Atherosclerotic Lesions With In Vivo Multicontrast Magnetic Resonance Imaging	591
Lipoprotein(a) and Coronary Heart Disease	590
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.	590
Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction	590
Proposed Diagnostic Criteria for the Brugada Syndrome	587
Relationship Between Spectral Components of Cardiovascular Variabilities and Direct Measures of Muscle Sympathetic Nerve Activity in Humans	586
Stability and Instability: Two Faces of Coronary Atherosclerosis	585
Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure	585
Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.	585
Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Proje	585
The problem of valve prosthesis-patient mismatch.	584
Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation.	584
C-Reactive Protein as a Cardiovascular Risk Factor	583
Exercise Myocardial Perfusion SPECT in Patients Without Known Coronary Artery Disease	583
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article	582
Adrenergic effects on the biology of the adult mammalian cardiocyte.	580
Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells	579
Intravascular Ultrasound	576
Accumulated Evidence on Fish Consumption and Coronary Heart Disease Mortality	576
Estimation of Infarct Size in Man and its Relation to Prognosis	575
Technique and Results of Linear Ablation at the Mitral Isthmus	575
Restenosis after successful coronary angioplasty in patients with single-vessel disease.	574
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension	573
Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis	573
Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With α _v β ₃ -Integrin–Targeted Nanoparticles	573
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.	572
Healed Plaque Ruptures and Sudden Coronary Death	571
Clinical and Pathophysiological Implications of a Bicuspid Aortic Valve	569
In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction	569
Delayed Development of Ventricular Ectopic Rhythms following Experimental Coronary Occlusion	568
Therapeutic Hypothermia After Cardiac Arrest	568
QT interval prolongation as predictor of sudden death in patients with myocardial infarction.	567
Selecting Patients With Atrial Fibrillation for Anticoagulation	567
Cellular Basis for the Electrocardiographic J Wave	565
Oxidative Stress and Cardiovascular Injury	565
Sudden Death as a Complication of Anomalous Left Coronary Origin From the Anterior Sinus of Valsalva	565
Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation.	564
The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris.	563
Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure	563
Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose Tissue	563
Arterial Remodeling After Coronary Angioplasty	562
Symptoms of Depression, Acute Myocardial Infarction, and Total Mortality in a Community Sample	561
A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.	561
Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac Cachexia	561
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity	560
Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency	560
Assessing Adiposity	560
Inhalation of Fine Particulate Air Pollution and Ozone Causes Acute Arterial Vasoconstriction in Healthy Adults	559
Epidemiology of Hypertrophic Cardiomyopathy–Related Death	557
Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy	557
Low Heart Rate Variability in a 2-Minute Rhythm Strip Predicts Risk of Coronary Heart Disease and Mortality From Several Causes	557
Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels	555
Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.	554
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke	554
Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation.	553
Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype	553
Catheter Ablation of Paroxysmal Atrial Fibrillation Initiated by Non–Pulmonary Vein Ectopy	552
Long QT Syndrome Patients With Mutations of the SCN5A and HERG Genes Have Differential Responses to Na ⁺	552
Cardiovascular Complications of Cancer Therapy	551
Quantification of Macrophage Content in Atherosclerotic Plaques by Optical Coherence Tomography	551
Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.	550
Stable Microreentrant Sources as a Mechanism of Atrial Fibrillation in the Isolated Sheep Heart	550
Advanced Coronary and Carotid Arteriopathy in Young Adults With Childhood-Onset Chronic Renal Failure	550
Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.	550
Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique.	550
Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal Detection	550
Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart Disease	550
Recurrent sustained ventricular tachycardia. 1. Mechanisms.	548
Ethnic Differences in Coronary Calcification	548
Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitativ	548
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion.	548
Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China.	548
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo	546
Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome	545
Chronic Heart Failure in the United States	544
Estimating Effectiveness of Cardiac Arrest Interventions	544
Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease	544
T ⁻⁷⁸⁶ →C Mutation in the 5′-Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary Spasm	544
Pathophysiologically Relevant Concentrations of Tumor Necrosis Factor-α Promote Progressive Left Ventricular Dysfunction and Remodeling in Rats	544
Obesity, Insulin Resistance, Diabetes, and Cardiovascular Risk in Children	544
ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary Article	544
Diagnostic efficiency of troponin T measurements in acute myocardial infarction.	543
National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines	543
Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques.	543
Endothelial Dysfunction in Pulmonary Hypertension	542
Intracoronary Stenting and Angiographic Results	542
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.	542
Mechanisms and Models in Heart Failure	541
Ischemic Stroke Subtype Incidence Among Whites, Blacks, and Hispanics	541
Endothelial Function	540
Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations.	540
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.	540
Evidence for Possible Involvement of 5-HT _2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications	540